Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | +10.53% |
|
+13.51% | +20.00% |
Jun. 20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
Jun. 12 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.00% | 33.2M | |
-3.18% | 793M | |
-31.56% | 212M | |
0.00% | 125M | |
-26.78% | 86.29M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies : Says Chief Executive Shirazi Leaving Company; John Trikola Appointed Interim CEO